Involved-field radiotherapy is effective for patients 70 years old or more with early stage non-small cell lung cancer

Radiotherapy and Oncology

Volumn 87, Issue 1, 2008, Pages 29-34

  Yu, Hui Ming ^a   Liu, Yun Fang ^b   Yu, Jin Ming ^c   Liu, Jie ^d   Zhao, Yuxia ^a   Hou, Ming ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

^c SHANDONG CANCER HOSPITAL AND INSTITUTE   (China)

^d SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Clinical trial; Intensity modulated radiotherapy; Involved field radiation therapy; Non small cell lung carcinoma

Indexed keywords

AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; ESOPHAGITIS; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INVOLVED-FIELD RADIOTHERAPY; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; LYMPH NODE; MALE; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION PNEUMONIA; SURVIVAL RATE; TREATMENT FAILURE; TREATMENT RESPONSE; TUMOR VOLUME;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 41849138318     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.01.008     Document Type: Article

References (34)

1. Jeremic B., Classen J., and Bamberg M. Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 54 (2002) 119-130
2. Cheung P.C., Mackillop W.J., Dixon P., et al. Involved-field radiotherapy alone for early-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 48 (2000) 703-710
3. Hayakawa K., Mitsuhashi N., Saito Y., et al. Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer 26 (1999) 137-142
4. Zhao L.J., West B.T., Hayman J.A., et al. High radiation dose may reduce the negative effect of large gross tumor volume in patients with medically inoperable early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 68 (2007) 103-110
5. Bral S., Parijs H.V., Soete G., et al. A feasibility study of image-guided hypofractionated conformal arc therapy for inoperable patients with localized non-small cell lung cancer. Radiat Oncol 84 (2007) 252-256
6. Morita k., Fuwa N., Suzuki Y.S., et al. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: a retrospective analysis of 149 patients. Radiat Oncol 42 (1997) 31-36
7. Koto M., Takai Y., Ogawa Y., et al. A phase II study on stereotactic body radiotherapy for stage I non-small cell lung cancer. Radiat Oncol 85 (2007) 429-434
8. Krol A.D., Aussems P., Noordijik E.M., et al. Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation?. Int J Radiat Oncol Biol Phys 34 (1996) 297-302
9. Noordijk E.M., vd Poest Clement E., Hermans J., et al. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer. Radiother Oncol 13 (1988) 83-89
10. Kupelian P.A., Komaki R., and Allen P. Prognostic factors in the treatment of node-negative non-small cell lung carcinoma with radiotherapy alone. Int J Radiat Oncol Biol Phys 36 (1996) 607-613
11. Grills I.S., Yan D., Martinez A.A., et al. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys 57 (2003) 875-890
12. Murshed H., Liu H.H., Liao Z., et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1258-1267
13. Fang L.C., Komaki R., Allen P., et al. Comparison of outcomes for patients with medically inoperable Stage I non-small-cell lung cancer treated with two-dimensional vs three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 108-116
14. Langer C.J. Elderly patients with lung cancer: biases and evidence. Curr Treat Options Oncol 3 (2002) 85-102
15. Nugent W.C., Edney M.T., Hammerness P.G., et al. Non-small cell lung cancer at the extremes of age: impact on diagnosis and treatment. Ann Thorac Surg 63 (1997) 193-197
16. Faria S.L., Souhami L., Portelance L., Duclos M., Vuong T., and Small D. Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer. Radiat Oncol 1 (2006) 42-48
17. McGarry R.C., Papiez L., Williams M., et al. Stereotactic body radiation therapy of early-stage non-small-cell lung carcinoma: phase I study. Int J Radiat Oncol Biol Phys 15,63 (2005) 1010-1015
18. Hayakawa K., Mitsuhashi N., Katano S., et al. High-dose radiation therapy for elderly patients with inoperable or unresectable non-small cell lung cancer. Lung Cancer 32 (2001) 81-88
19. Gauden S.J., and Tripcony L. The curative treatment by radiation therapy alone of stage I non-small cell lung cancer in a geriatric population. Lung Cancer 32 (2001) 71-79
20. Rosenzweig K.E., Sura S., Jackson A., et al. Involved-field radiation therapy for inoperable non small-cell lung cancer. J Clin Oncol 25 (2007) 5557-5561
21. De Ruysscher D, Wanders R, van Haren E, et al. HI-CHART: a phase I/II study on the feasibility of high-dose continuous hyperfractionated accelerated radiotherapy in patients with inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2007 Nov 23.
22. Hoyer M., Roed H., Hansen A.T., et al. prospective study on stereotactic radiotherapy of limited-stage non-small -cell lung cancer. Int J Radiat Oncol Biol Phys 64 (2006) s128-s135
23. Wulf J., Haedinger U., Oppitz U., et al. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 60 (2004) 186-196
24. Hiraoka M., M atsuo Y., and Nagata Y. Stereotactic body radiation therapy (SBRT) for early-stage lung cancer. Cancer Radiother 11 (2007) 32-35
25. Chapet O., Khodri M., Jalade P., et al. Potential benefits of using non coplanar field and intensity modulated radiation therapy to preserve the heart in irradiation of lung tumors in the middle and lower lobes. Radiother Oncol 80 (2006) 333-340
26. Sibley G.S., Jamieson T.A., Marks L.B., et al. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the duke experience. Int J Radiat Oncol Biol Phys 40 (1998) 149-154
27. Tingyi X., Hongqi L., Qingxuan S., et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 66 (2006) 117-125
28. Rosenzweig K.E., Sim S.E., Mychalczak B., Braban L.E., Schindelheim R., and Leibel S.A. Elective nodal irradiation in the treatment of non small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 50 (2001) 681-685
29. Sibley G.S. Radiation therapy for patients with medically inoperable stage I non small cell lung carcinoma: smaller volumes and higher doses - a review. Cancer 82 (1998) 433-438
30. Perez C.A., Pajak T.F., and Rubin P. Long-term observations of the patterns of failure with unresectable non-small cell carcinoma of the lung treated with definitive radiotherapy. Cancer 59 (1987) 1874-1881
31. Kong F.M., Ten Haken R.K., Schipper M.J., et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 324-333
32. Jeremic B. Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in non-small cell lung cancer (NSCLC): enough to convert no-elective into elective nodal irradiation (ENI)?. Radiother Oncol 71 (2004) 123-125
33. Belderbos J.S., Heemsbergen W.D., De Jaeger K., Baas P., and Lebesque J.V. Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 126-134
34. Slotman B.J., Njo K.H., and Karim A.B. Curative radiotherapy for technically operable stage I non-small cell lung cancer. Int J Radiat Oncol Biol Phys 29 (1994) 33-37